Hamilton Wealth LLC Has $669,000 Holdings in Centene Corporation $CNC

Hamilton Wealth LLC increased its position in shares of Centene Corporation (NYSE:CNCFree Report) by 128.5% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 16,246 shares of the company’s stock after buying an additional 9,136 shares during the period. Hamilton Wealth LLC’s holdings in Centene were worth $669,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of CNC. Baird Financial Group Inc. acquired a new position in shares of Centene in the 1st quarter valued at about $236,000. Sivia Capital Partners LLC increased its holdings in Centene by 80.0% in the second quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after purchasing an additional 4,315 shares in the last quarter. CW Advisors LLC lifted its stake in Centene by 20.3% in the second quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock valued at $264,000 after buying an additional 820 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares in the last quarter. Finally, Treasurer of the State of North Carolina grew its position in shares of Centene by 0.4% during the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after buying an additional 967 shares during the period. Institutional investors own 93.63% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. TD Cowen reiterated a “hold” rating and set a $47.00 target price (up from $38.00) on shares of Centene in a research report on Monday, May 4th. Robert W. Baird lifted their price target on shares of Centene from $36.00 to $37.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Wells Fargo & Company increased their price objective on shares of Centene from $44.00 to $56.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Truist Financial raised their target price on Centene from $58.00 to $71.00 and gave the company a “buy” rating in a research note on Monday, June 1st. Finally, JPMorgan Chase & Co. upped their price target on Centene from $52.00 to $60.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Centene currently has an average rating of “Hold” and a consensus price target of $60.24.

Get Our Latest Research Report on Centene

Centene Stock Up 0.7%

Centene stock opened at $61.06 on Friday. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $66.55. The stock has a market cap of $30.15 billion, a PE ratio of -4.65, a price-to-earnings-growth ratio of 0.47 and a beta of 1.09. The firm’s 50-day simple moving average is $53.52 and its 200 day simple moving average is $44.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12.

Centene (NYSE:CNCGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, beating the consensus estimate of $2.23 by $1.14. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The firm had revenue of $49.94 billion during the quarter, compared to analyst estimates of $47.53 billion. During the same quarter last year, the business posted $2.90 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. Research analysts predict that Centene Corporation will post 3.45 EPS for the current fiscal year.

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

Further Reading

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.